Prandin (Carilion Materials Management)
Welcome to the PulseAid listing for the Prandin drug offered from Carilion Materials Management. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | repaglinide |
SUBSTANCE NAME: | REPAGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2000-01-03 |
END MARKETING DATE: | 0000-00-00 |
Prandin HUMAN PRESCRIPTION DRUG Details:
Item Description | Prandin from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2000-01-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-3565_624c09fd-c120-49f4-990b-8cad53ab4a20 |
PRODUCT NDC: | 68151-3565 |
APPLICATION NUMBER: | NDA020741 |
Other REPAGLINIDE Pharmaceutical Manufacturers / Labelers: